Rift Valley fever (RVF) is a mosquito-borne zoonotic disease endemic to Africa and the Middle East, affecting both humans and ruminants. There are no licensed vaccines or antivirals available for humans, whereas research using RVF virus (RVFV) is strictly regulated in many countries with safety concerns. Nonpathogenic Arumowot virus (AMTV), a mosquitoborne phlebovirus in Africa, is likely useful for the screening of broad-acting antiviral candidates for phleboviruses including RVFV, as well as a potential vaccine vector for RVF. In this study, we aimed to generate T7 RNA polymerase-driven reverse genetics system for AMTV. We hypothesized that recombinant AMTV (rAMTV) is viable, and AMTV NSs protein is dispensable for efficient replication of rAMTV in type-I interferon (IFN)-incompetent cells, whereas AMTV NSs proteins support robust viral replication in type-I IFN-competent cells. The study demonstrated the rescue of rAMTV and that lacking the NSs gene (rAMTVΔNSs), that expressing green fluorescent protein (GFP) (rAMTV-GFP) or that expressing Renilla luciferase (rAMTV-rLuc) from cloned cDNA. The rAMTV-rLuc and the RVFV rMP12-rLuc showed a similar susceptibility to favipiravir or ribavirin. Interestingly, neither of rAMTV nor rAMTVΔNSs replicated efficiently in human MRC-5 or A549 cells, regardless of the presence of NSs gene. Little accumulation of AMTV NSs protein occurred in those cells, which was restored via treatment with proteasomal inhibitor MG132. In murine MEF or Hepa1-6 cells, rAMTV, but not rAMTVΔNSs, replicated efficiently, with an inhibition of IFN-β gene upregulation. This study showed an establishment of the first reverse genetics for AMTV, a lack of stability of AMTV NSs proteins in human cells, and an IFN-β gene antagonist function of AMTV NSs proteins in murine cells. The AMTV can be a nonpathogenic surrogate model for studying phleboviruses including RVFV. 
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Introduction
Rift Valley fever (RVF) is one of the most important zoonotic viral diseases for public health, which is classified as Category A Priority Pathogen by the National Institute of Allergy and Infectious Diseases in the United States (U.S.) and the Blueprint priority disease by the World Health Organization [1, 2] . RVF had been endemic to sub-Saharan Africa, and has spread into Egypt, Madagascar, the Comoros, Saudi Arabia, and Yemen [3] . RVF is characterized by a high rate of abortions and fetal malformations in pregnant ewes, goats or cattle, and high mortality of newborn lambs or goat kids due to acute liver necrosis [4] . In humans, most patients suffer from self-limiting febrile illness, whereas some patients develop hemorrhagic fever, encephalitis, or vison loss [5] . Despite devastating outcomes of past RVF outbreaks, there are no licensed vaccines or antivirals available for humans. In the U.S., the handling of RVFV, which is a risk group 3 pathogen, requires biosafety level (BSL) 3 or 4 laboratory, whereas the possession, use, and transfer of RVFV are strictly under control of federal select agent program. A live-attenuated MP-12 vaccine strain is excluded from the select agent list and can be handled in BSL2 in the U.S., yet most other countries still require BSL3 for the handling of MP-12 strain. Nevertheless, the use of RVFV is required for basic and translational research to develop countermeasures against RVF. The reverse genetics is the technology to rescue infectious recombinant RNA viruses from cloned cDNA [6] . It allows manipulation of RNA virus genome, which has contributed to virology and vaccinology since the discovery. RVFV has also been rescued from cloned cDNA [7] . Recombinant MP-12 (rMP-12), including that expressing reporter gene, has been generated for the use in BSL2 for basic virology, antiviral screening and vaccine sciences. A development of reverse genetics system for other phleboviruses has been reported for Uukuniemi virus (UUKV) or Severe Fever with Thrombocytopenia Syndrome virus (SFTSV) [8] [9] [10] . UUKV and SFTSV are transmitted by ticks, and phylogenetically related to RVFV distantly. Recently, SFTSV was renamed as Huaiyangshan banyangvirus and reclassified into the genus Banyangvirus.
The order Bunyavirales, which consists of 12 families and 45 genera, contains at least 289 viral species with tripartite genomic RNA, comprising Large (L), Medium (M), and Small (S) segments [11] . The genus Phlebovirus within the family Phenuiviridae contains ten viral species (Bujaru, Candiru, Chilibre, Frijoles, Punta Toro, Rift Valley fever, Salehabad, Sandfly fever Naples, Mukawa, and Uukuniemi phleboviruses); meanwhile, many distinct phleboviruses that are phylogenetically close to those ten species remain unclassified. Many of those unassigned phleboviruses are cross-reactive to one of the ten phlebovirus species in serological assays, forming species complexes within the genus [12] [13] [14] [15] [16] . Arthropod vectors, including mosquitoes, sandflies, and ticks, play a major role in phleboviral transmission in nature and a number of the abovementioned viruses, specifically RVFV, Arumowot virus (AMTV), Odrenisrou virus, Icoaraci virus, and Itaporanga virus, are known to be transmitted via mosquitoes [17] . Geographically, RVFV, AMTV, and Odrenisrou virus are distributed in Africa, whereas the Icoaraci and Itaporanga viruses are present in South America.
In this study, we aimed to generate T7 RNA polymerase-driven reverse genetics system for AMTV, because AMTV is a mosquito-borne phlebovirus endemic to Africa, which is likely an excellent surrogate model to study virological similarity with pathogenic RVFV. AMTV remains unclassified, yet likely belongs to the Salehabad species complex [14] . It is widely distributed throughout the RVF-endemic region in Africa, where it has been isolated from Culex antennatus, C. rubinotus, Mansonia uniformis, Tatera kempii (gerbil), Arbicanthis noloticus (African grass rat), Thamnomys macmillani (wild rat), Lemnyscomys striatus (typical striped grass mouse), Crocidura sp. (shrew), and Turdus libonyanus (Kurrichane thrush) [18, 19] The nonstructural protein S (NSs protein) of RVFV is a major virulence factor, which promotes the post-translational degradation of dsRNA-dependent protein kinase (PKR) and transcription factor (TF) IIH subunit p62 [24] [25] [26] [27] [28] [29] , and interacts with TFIIH p44 subunit and sin3A associated protein 30 [30, 31] . RVFV-infected cells undergo general transcriptional suppression due to the failure of TFIIH assembly, whereas IFN-β gene up-regulation can be inhibited due to a failure of promoter activation at transcriptional level [32] . Pathogenic SFTSV encodes NSs proteins, which inhibit IFN-β gene up-regulation and the signaling pathway via forming inclusion bodies sequestering IFN regulatory factor 3 (IRF3) or cellular signal transducer and activator of transcription 2 (STAT2) [33] [34] [35] . NSs protein of nonpathogenic UUKV was dispensable for the replication in type-I IFN competent A549 cells, yet the replication was increased up to 10-fold with the expression of NSs protein via weakly inhibiting type-I IFNs [9] . We hypothesized that AMTV NSs protein is dispensable for efficient replication of recombinant AMTV (rAMTV) in type-I IFN-incompetent cells, whereas AMTV NSs proteins support robust viral replication in type-I IFN-competent cells. This study shows an establishment of the first reverse genetics for AMTV, a mosquito-borne phlebovirus distinct from RVFV, and the characterization of recombinant AMTV with and without NSs genes in human and murine cells.
ATCC CCL-185), human uterus endometrium (Hec1B, ATCC HTB-113), mouse hepatoma (Hepa1-6, ATCC CRL-1830), and mouse embryonic fibroblast (MEF-BL/6-1, ATCC SCRC-1008) cells were maintained at 37˚C with 5% CO 2 in Dulbecco's modified minimum essential medium containing 10% fetal bovine serum (FBS), penicillin (100 U/ml), and streptomycin (100 μg/ml). Baby hamster kidney cells that stably expressed T7 RNA polymerase (BHK/T7-9 cells) [36] were maintained at 37˚C with 5% CO 2 in minimum essential medium alpha containing 10% FBS, penicillin (100 U/ml), streptomycin (100 μg/ml), and hygromycin B (600 μg/ ml). All cells used in this study were verified to be mycoplasma free at the University of Texas Medical Branch at Galveston (UTMB) Tissue Culture Core Facility, and the identities of MRC-5, A549, and Hec1B cells were authenticated by Short Tandem Repeat analysis (UTMB Molecular Genomics Core Facility). AMTV Ar 1286-64 strain (wt AMTV: originally isolated from Culex antennatus in Sudan in 1963, and passaged in suckling mice twice and in Vero cells once) was kindly provided by Dr. Robert B. Tesh of the University of Texas Medical Branch at Galveston (UTMB) via the World Reference Center for Emerging Viruses and Arboviruses. AMTV was plaque-cloned once and then amplified three times in Vero cells before experimental use. Rescued rAMTV, rAMTV lacking the NSs gene (rAMTVΔNSs), or rAMTV encoding green fluorescent protein (GFP) gene in place of AMTV NSs gene (rAMTV-GFP) were also amplified once in Vero cells after their recovery using BHK/T7-9 cells. A parental rMP-12 or rMP-12 encoding an in-frame 69% deletion of the NSs gene (rMP12-ΔNSs16/198, alternative name: rMP12-C13type) has been previously described [7] . The rMP-12 encoding GFP gene in place of MP-12 NSs gene (rMP12-GFP), or that encoding AMTV NSs gene in place of MP-12 NSs gene (rMP12-AMTVNSs) were amplified once in Vero cells after their recovery using BHK/T7-9 cells. All stock viruses were sequenced (Sanger sequencing), titrated via plaque assay using Vero E6 cells, and then used for subsequent experiments.
Plasmids
Plasmids encoding positive-sense L-, M-, or S-segments of AMTV prototype strain, Ar 1286-64 (GenBank accession numbers; MF593931-MF593933), flanked by an upstream T7 promoter (non-templated 2G in T7 promoter) and a downstream hepatitis delta virus ribozyme, were prepared using a custom DNA synthesis service (GenScript Inc.), and designated pProT7-AMTV-S(+), pProT7-AMTV-M(+), or pProT7-AMTV-L(+), respectively. Plasmids expressing N, L, or Gn/Gc proteins of AMTV were also prepared by subcloning the open reading frame (ORF) of each gene into pCAGGS or pT7-IRES plasmids, and designated pCAGGS-AMTV-N, pT7-IRES-AMTV-L, or pCAGGS-AMTV-G, respectively [37] . The pProT7-AMTV-S(+)-ΔNSs plasmid, which encodes AMTV S-segment with a 97% in-frame truncation (aa. 9 to aa. 249) within the NSs ORF (267 amino acids), was constructed via sitedirected mutagenesis, whereas the pProT7-AMTV-S(+)-GFP or pProT7-AMTV-S(+)-rLuc plasmids were generated by replacing the NSs ORF with GFP or rLuc ORF, respectively. The pSPT18-AMTV-S plasmid was constructed by subcloning a partial AMTV N ORF into the pSPT18 plasmid (Sigma-Aldrich).
Rescue of recombinant viruses
For the rescue of rAMTV from cloned cDNA, subconfluent monolayers of BHK/T7-9 cells in 60-mm dishes were co-transfected with 1.5 μg of pProT7-AMTV-S(+), 1.5 μg of pProT7-AMTV-M(+), 1.5 μg of pProT7-AMTV-L(+), 2.8 μg of pCAGGS-AMTV-N, 0.35 μg of pT7-IRES-AMTV-L, or 1.4 μg of pCAGGS-AMTV-G, using TransIT-293 transfection reagent (Mirus Bio LLC.). At 24 hours post-transfection, the culture medium was replaced with fresh medium. Five days after transfection, the culture supernatants were transferred into Vero cells for further viral amplification. For the rescue of rAMTV-ΔNSs, rAMTV-GFP, or rAMTVrLuc, 1.5 μg of the pProT7-AMTV-S(+)-ΔNSs, pProT7-AMTV-S(+)-GFP, or pProT7-AMTV-S(+)-rLuc plasmid were used, respectively, in place of the pProT7-AMTV-S(+) plasmid. Rescue of rMP12-GFP, rMP12-rLuc, or rMP12-AMTVNSs was conducted using the same protocol described previously [7, 38] .
Viral replication kinetics study
The replication kinetics of rAMTV, or rAMTVΔNSs were tested in Vero, MRC-5, A549, Hepa1-6, and MEF cells (MOI of 0.01), whereas the replication kinetics of rMP-12, rMP12-ΔNSs16/198, or rMP12-AMTVNSs were tested in MRC-5, or Hepa1-6 cells (MOI of 0.01). After one hour incubation at 37˚C, cells were washed three times with PBS, and then further incubated at 37˚C. Culture supernatants were harvested at 1, 24, 48, 72, and 96 hours post infection (hpi), and viral titers were measured by plaque assay. The replication kinetics of rAMTV-GFP or rMP12-GFP were also tested in Vero cells, and titers were measured by focusforming assay detecting the GFP signals of infected cells. Growth curves were calculated using means and standard deviations from three independent experiments.
Western blot analysis
For the detection of AMTV protein synthesis, Vero cells were mock-infected or infected with wt AMTV, rAMTV, or rAMTVΔNS at 2 MOI, and lysates were collected at 8 or 16 hpi. For the detection of AMTV NSs protein, MEF, Hepa1-6, MRC-5, or A549 cells were mockinfected or infected with rMP12-AMTVNSs at 3 MOI, and lysates were collected at 16 or 24 hpi. For the analysis of IRF3 phosphorylation, Hepa1-6 cells were mock-infected or infected with rMP12-ΔNSs16/198 or rMP12-AMTVNSs at 10 MOI, and lysates were collected at 8 hpi. Western blot analysis was performed using Immobilon P polyvinylidene fluoride membranes (Millipore), as described previously [37] . The following primary antibodies were used: anti-AMTV N peptide rabbit polyclonal antibody (peptide N-KLIIERGGNNWKEDAK-C, ProSci Inc.), anti-AMTV NSs rabbit polyclonal antibody (custom antibody production via Proteintech group, using recombinant whole AMTV NSs with a Nus-tag and His-tag prepared via the UTMB Protein Chemistry Core), anti-RVFV hyper-immune mouse ascetic fluid (kindly provided by Dr. R. B. Tesh at UTMB), anti-IRF3 rabbit monoclonal antibody (Cell Signaling Technologies), anti-phosphorylated IRF3 Ser396 (Cell Signaling Technologies), anti-phosphorylated IRF3 Ser386 (Sigma Aldrich), anti-actin goat polyclonal antibody, anti-β-actin goat polyclonal antibody, anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) goat polyclonal antibody (Santa Cruz Biotechnology). The following secondary antibodies were used: goat anti-mouse IgG-horseradish peroxidase (HRP) antibody (Santa Cruz Biotechnology), goat anti-rabbit IgG-HRP antibody (Invitrogen), or donkey anti-goat IgG-HRP antibody (Santa Cruz Biotechnology). For the inhibition of proteasome, lysosome, or cellular transcription, cells were treated with MG132 (5, 10, or 20 μM), chloroquine (10, 50, or 100 μM), or actinomycin D (1, 3, or 5 μg/ml) (Sigma-Aldrich), respectively, starting at 1 hpi. 
Analysis of the cell number expressing GFP

Inhibition of rAMTV-rLuc or rMP12-rLuc by broadly-active antivirals
Vero cells were mock-infected or infected with rAMTV-rLuc or rMP12-rLuc at 2 MOI. After 1 hour adsorption at 37˚, cells were treated with 1, 10, or 100 μg/ml of favipiravir (Selleck Chemicals) or ribavirin (Sigma Aldrich). As a control, cells were treated with DMSO at the amount equivalent to that used for 100 μg/ml of favipiravir or ribavirin. Culture supernatants were collected at 1 hpi and 24 hpi, and virus titers (PFU/ml) were measured by plaque assay. Cell lysates were harvested at 24 hpi, and rLuc activities were measured by Renilla Luciferase Assay System (Promega), according to the manufacturer's instructions. The relative rLuc activities were normalized to the protein concentrations of lysates, which were measured by Qubit Protein Assay Kit (Thermo Fisher Scientific).
Northern blot analysis
MRC-5 cells were mock-infected or infected with wt AMTV, rAMTV, or rAMTVΔNSs at 2 MOI, and total RNA was extracted using the TRIzol reagent (Invitrogen) at 8 or 16 hpi. Approximately 100 ng of denatured RNA were separated on 1% denaturing agarose-formaldehyde gels and transferred onto a nylon membrane (Roche Applied Science). Northern blot analysis was performed, as described previously [39] , with strand-specific RNA probes to detect antiviral-sense AMTV S-segment RNA within the N ORF. A RNA probe for the AMTV S-segment was newly generated from pSPT18-AMTV-S plasmid via in vitro transcription, using the DIG RNA Labeling Kit (Sigma-Aldrich) according to the manufacturer's instructions. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA was also detected to visualize the level of cellular RNA.
Droplet digital PCR
MRC-5 or Hepa1-6 cells were mock-infected or infected with 2 MOI of rAMTV or rAMTVΔNSs, or 10 MOI of rMP12-AMTVNSs, rMP-12, or rMP12-ΔNSs16/198. Total RNA was collected at 4, 8, or 16 hpi, and the copy numbers of human or murine IFN-β mRNA were analyzed by droplet digital PCR (ddPCR) using the QX100 droplet generator and reader (BioRad Laboratories), as described previously [40] . Total RNA was extracted using the RNeasy mini kit (Qiagen), according to the manufacturer's instructions. The concentration of extracted RNA was measured with a Qubit 2.0 Fluorometer (Thermo Fisher Scientific), and first-strand complementary DNA (cDNA) was synthesized using iScript (Bio-Rad Laboratory). PCR reactions were prepared as follows: 250 nM of TaqMan probe, 900 nM of primer, ddPCR Supermix for Probes (Bio-Rad Laboratory), cDNA, and water (up to 25 μl). PCR cycling parameters included an initial denaturation step (95˚C for 10 minutes), followed by 40 cycles of 94˚C for 30 seconds, 60˚C for 1 minute, and a final denaturation step of 98˚C for 10 minutes.
For the measurement of human IFN-β mRNA copy number, ddPCR was conducted using a Taqman probe, 5'-(5' Hexachloro-Fluorescein, HEX) CAA TTG AAT GGG AGG CTT GAA TAC (Black Hole Quencher 1, BHQ1)-3'; forward primer, 5'-TCA GTG TCA GAA GCT CCT GT-3'; and reverse primer, 5'-GTT CAT CCT GTC CTT GAG GC-3'. For the measurement of murine IFN-β mRNA copy number, a different Taqman probe, 5'-(HEX) TGG AGA TGA CGG AGA TGC AGA (BHQ1)-3'; forward primer, 5'-TAC AGG GCG GAC TTC AAG AT-3'; and reverse primer, 5'-TGG CAA AGG CAG TGT AAC TC-3', were used. The number of droplets with positive and negative signals was measured using the QX100 droplet reader. Data analysis was performed using QuantaSoft Version 1.4 (Bio-Rad Laboratory).
Statistical analysis
Statistical analyses were performed using GraphPad Prism 6.05 (GraphPad Software Inc.). For comparisons among groups of viral titers or RNA copy numbers, arithmetic means of log 10 values were analyzed by unpaired t-test (two samples), or one-way ANOVA, followed by Tukey's multiple comparison test (more than two samples).
Ethics statement
The RVFV MP-12 strain, rMP-12 strains, AMTV, and rAMTV strains, as well as recombinant DNA, were used upon approval of the Notification of Use by the Institutional Biosafety Committee at UTMB.
Results
Rescue of infectious AMTV from cloned cDNA
The T7 RNA polymerase-driven reverse genetics system, which has previously been used for the rescue of RVFV [7] , was applied to rescue rAMTV strains. BHK/T7-9 cells were transfected with six plasmids expressing full-length genomic RNA (AMTV L-, M-, and S-segments) and structural viral proteins (AMTV N, L, and GnGc). At 5 days post transfection, culture supernatants were further amplified in Vero cells. Schematic representations of the S-segments of rAMTV and rAMTVΔNSs are shown in Fig 1A. Those AMTV strains were rescued successfully and showed a similar plaque morphology with wt AMTV in Vero E6 cells (Fig 1B) . To confirm the expression of AMTV proteins, Vero cells were mock-infected or infected with wt AMTV, rAMTV, or rAMTVΔNSs (2 MOI). Western blot analysis using anti-AMTV-N antibody or anti-AMTV-NSs antibody showed that AMTV N protein accumulated in Vero cells infected with wt AMTV, rAMTV, or rAMTVΔNSs, whereas AMTV NSs protein was only detectable in cells infected with wt AMTV or rAMTV, not those with rAMTVΔNSs (Fig 1C) .
Characterization of rAMTV-GFP replication
Previous study showed that recombinant RVFV can express reporter gene from NSs gene [7] . Since the expression of GFP from AMTV will enable real-time detection of virus-infected cells without plaque assay or immunofluorescent assay, we next aimed to generate rAMTV expressing GFP, in place of NSs gene (rAMTV-GFP). Infectious rAMTV-GFP could be rescued from cloned cDNA successfully, and replicated as efficiently as recombinant RVFV MP-12 strain expressing GFP (rMP12-GFP), in Vero cells (Fig 2A) . We used Vero cells (African green monkey kidney cells), because this cell line is susceptible to most phleboviruses due to lack the IFN-alpha/beta genes, and commonly used for virus amplification [41, 42] . The GFP expression pattern of rAMTV-GFP-infected Vero cells was indistinguishable from that of rMP12-GFP-infected Vero cells, whereas rAMTV-GFP infection led to detectable cytopathic effect at 48 hpi (Fig 2B) . Since little is known about the infectivity of AMTV in culture cells, we next measured the number of GFP-expressing cells using several different culture cells derived from human or mice. Based on known susceptibility to RVFV MP-12 strain [43] [44] [45] [46] Fig 2C) ; the GFP signals derived from rAMTV-GFP were seen in 11.4%, 16.6%, 0.5%, 2.3%, 1.3%, or 0.8% of Vero, Hec1B, MRC-5, A549, Hepa1-6, or MEF cells, respectively, whereas those from rMP12-GFP were seen in 41.3%, 11.8%, 5.5%, 9.7%, 0.7%, or 2.9%, respectively. The result indicated that Vero and Hec1B cells support the replication of rAMTV-GFP better than did MRC-5, A549, Hepa1-6, or MEF cells. Since rAMTV-GFP lacks NSs gene, it was possible that the replication of rAMTV-GFP was more restricted in type-I IFN-competent MRC-5, A549, Hepa1-6, or MEF cells than in type-I IFN-incompetent Vero or Hec1B cells. Generation of rAMTV-rLuc as a surrogate for rMP12-rLuc in antiviral screening assays
The rMP12-rLuc, which expresses Renilla luciferase (rLuc) in place of NSs protein, has been used for antiviral screening in past studies [49] [50] [51] [52] . Although the rMP12-rLuc is not pathogenic in animals and humans, works in BSL-3 facility will be required to handle MP-12 strain and the variants in most countries other than the U.S. Accordingly, surrogate viruses for rMP12-rLuc will likely be useful for antiviral screening in many countries. The median effective concentrations (EC 50 ) of broad-spectrum antivirals, favipiravir (T-705, 6-fluoro-3-hydroxy-2-pyrazinecarboxamide) or ribavirin, for a Vero cell-based virus yield reduction assay against bunyaviruses were reported to be 5-30 μg/ml, or 13-42 μg/ml, respectively [53] . We generated the rAMTV-rLuc, which expresses rLuc in placed of NSs protein, by using the reverse genetics system, and tested the susceptibility to favipiravir or ribavirin. As shown in Fig 3A , Vero cells were mock-infected or infected with rAMTV-rLuc or rMP12-rLuc, and treated with 1, 10, or 100 μg/ml of favipiravir or ribavirin. With the treatment of 10 or 100 μg/ ml of favipiravir, rAMTV-rLuc titers were reduced to 48 or 1%, and rMP12-rLuc titers were reduced to 56 or 4%, respectively. Similarly, with the treatment of 10 or 100 μg/ml of ribavirin, rAMTV-rLuc titers were reduced to 37 or 0.9%, and rMP12-rLuc titers were reduced to 53 or 1.8%, respectively. Different from infectious virus titers, the rLuc activities showed significant reduction at 100 μg/ml, but not 10 μg/ml, of favipiravir or ribavirin treatment (Fig 3B) . The rLuc activities of rAMTV-rLuc or rMP12-rLuc at 100 μg/ml of favipiravir were 24% or 23%, respectively, whereas those of rAMTV-rLuc or rMP12-rLuc at 100 μg/ml of ribavirin were 18% or 9%, respectively. The results showed that the rAMTV-rLuc and rMP12-rLuc are similarly susceptible to favipiravir or ribavirin, and the rLuc activities derived from rAMTV-rLuc or rMP12-rLuc can be useful for rapid screening of efficacious antivirals without performing time-consuming plaque assays.
Replication of rAMTV in type-I IFN competent cells
We next tested whether rAMTV expressing NSs protein can efficiently replicate in type-I IFN competent cells. MRC-5, A549, Hepa1-6, or MEF cells were infected with rAMTV or rAMTVΔNSs at MOI 0.01. Unexpectedly, neither rAMTV nor rAMTV-ΔNSs replicated efficiently in MRC-5 or A549 cells; i.e., peak titers of rAMTV were 2.0 x 10 3 or 6.6 x 10 3 PFU/ml in MRC-5 or A549 cells, respectively (Fig 4A) . In contrast, rAMTV replicated more efficiently than rAMTV-ΔNSs in MEF or Hepa1-6 cells; i.e., the peak titers of rAMTV were 7.5 x 10 6 PFU/ml (236 fold higher than rAMTV-ΔNSs titer) or 1.4 x 10 6 PFU/ml (25 fold higher than rAMTVΔNSs titer) in MEF or Hepa1-6 cells, respectively (Fig 4B) . The result indicated that AMTV NSs supports the replication of AMTV in type-I IFN-competent MEF or Hepa1-6 cells. In contrast, AMTV NSs protein apparently did not function in MRC-5 or A549 cells. Using Northern blot, the accumulation of AMTV S-segment RNA in MRC-5 cells was also analyzed (Fig 4C) . 
Reverse genetics for Arumowot virus
Although positive-sense AMTV S-segment RNA was detected in all infected samples at 8 hpi, AMTV N mRNA was poorly detected in MRC-5 cells infected with wt AMTV or rAMTV at 8 hpi, and more detectable at 16 hpi, confirming that AMTV RNA synthesis occurs in MRC-5 cells.
Expression of AMTV NSs from rMP-12 backbone
To further analyze the role of AMTV NSs proteins, we next transferred AMTV NSs gene into rMP-12 S-segment, in place of MP-12 NSs gene (Fig 5A) . MP-12 NSs protein can inhibit the 
Posttranslational degradation of AMTV NSs in human cells
To analyze the expression level of AMTV NSs proteins, MRC-5 were mock-infected or infected with rMP12-AMTVNSs at 3 MOI (Fig 6A) . Although MP-12 N proteins could be Fig 6C) . The result showed that MRC-5 or A549 cells promote post-translational degradation of AMTV NSs proteins via proteasome. The level of IFN-β mRNA upregulation was analyzed by ddPCR using total RNA extracted from MRC-5 cells, which were mock-infected or infected with rAMTV, rAMTVΔNSs, rMP-12, rMP12-AMTVNSs, or rMP12-ΔNSs16/198 (Fig 6D) . 
Inhibition of murine IFN-β gene upregulation by AMTV NSs proteins
Next, MEF or Hepa1-6 cells were mock-infected or infected with rMP12-AMTVNSs at 3 MOI (Fig 7A) . Different from MRC-5 or A549 cells, AMTV NSs proteins could be robustly accumulated in MEF or Hepa1-6 cells. Using total RNA extracted from Hepa1-6 cells, which were mock-infected or infected with rAMTV, rAMTVΔNSs, rMP-12, rMP12-AMTVNSs, or rMP12-ΔNSs16/198, RNA copy numbers of IFN-β mRNA were measured by using ddPCR. Analysis of copy numbers of murine IFN-β mRNA showed that rAMTV infection induced 1,967, 3,287, or 1554 copies per total RNA (μg) of murine IFN-β mRNA in Hepa1-6 cells at 4, 8, or 16 hpi, which was 1.5, 9.7, or 2.4 times more than that of mock-infected cells (Fig 7B) . [14, [57] [58] [59] [60] [61] [62] [63] . We could successfully rescue rAMTV lacking the NSs gene (rAMTVΔNSs) or rAMTV expressing GFP (rAMTV-GFP) or rLuc (rAMTV-rLuc). The rAMTV-GFP could express GFP along with viral replication, which is useful to detect infected cells real-time. The rMP-12 variants expressing reporter gene (e.g., rMP12-rLuc) have been used for screening of antiviral compounds or host genes affecting viral replication [49] [50] [51] [52] . The handling of MP-12 strain, however, still requires BSL-3 facility in many countries other than the U.S. AMTV is classified as a Risk Group 2 pathogen, and there are no known risk of human or animal diseases, which may be suitable for initial screening of broad-acting antivirals effective for both AMTV and RVFV worldwide. This study demonstrated that rAMTV-rLuc and rMP12-rLuc, which encodes rLuc gene in place of NSs gene in AMTV or MP-12 backbone, are similarly susceptible to broad-spectrum antivirals, favipiravir or ribavirin. The reduction of infectious virus titers were detectable at 10 μg/ml of favipiravir or ribavirin. Our study also showed a similar dose-dependent inhibition of rLuc activities from rAMTV-rLuc or rMP12-rLuc, by favipiravir or ribavirin treatment, yet the reduction of rLuc activities were detectable at 100 μg/ml, but not at 10 μg/ml. Since the transcription of NSs mRNA from antiviral-sense S-segment derived from virions can start immediately after infection [39] , it is likely that rLuc mRNA could be accumulated in infected cells before favipiravir or ribavirin could inhibit viral RNA synthesis. Although further optimization of the timing of antiviral treatment may be required, rapid detection of reduced rLuc activities will be a useful method to screen antivirals, without performing time-consuming plaque assays for a large number of samples. The reverse genetics system for AMTV can generate not only NSs gene variants, but various other mutant strains, which can serve as an excellent tool to study basic virology (e.g., consensus gene elements functional among phleboviruses) and vaccinology (e.g., bunyavirus vector for expressing RVF GnGc antigens for vaccine use).
Post-translational degradation of AMTV NSs proteins occurred via proteasomes in MRC-5 and A549 cells. This phenomenon partly explains the lack of type-I IFN antagonist function of AMTV NSs observed in MRC-5 cells. It remains unknown whether similar degradation of AMTV NSs proteins occurs in authentic human tissues infected with AMTV. Nevertheless, it is likely that AMTV NSs serves as a substrate of ubiquitination for proteasomal degradation at least in MRC-5 and A549 cells. RVFV Reverse genetics for Arumowot virus whereas Toscana virus NSs protein promotes the degradation of PKR and RIG-I [65, 66] . The mechanism of AMTV NSs protein degradation in human cells should be further characterized in future studies.
AMTV efficiently replicated in type-I IFN-competent murine MEF and Hepa1-6 cells, whereas replication was significantly impaired by a lack of AMTV NSs protein expression. Moreover, rMP12-AMTVNSs, but not rMP12-ΔNSs16/198, robustly replicated in both MEF and Hepa1-6 cells. We also noted that the replication of rMP12-AMTVNSs was more efficient than that of parental rMP-12 in MEF cells. Accordingly, AMTV NSs proteins might function as a strong antagonist in the murine type-I IFN induction pathway. Consistent with this hypothesis, rAMTV and rMP12-AMTVNSs, which express AMTV NSs protein, inhibited the induction of murine IFN-β mRNA in infected Hepa1-6 cells. Moreover, the phosphorylation of murine IRF3 at Ser 378 and 388 was not detectable in Hepa1-6 cells infected with rMP12-AMTVNSs. These results indicate that activation of IRF3 or the upstream kinases (e.g., RIG-I) might be inhibited by AMTV NSs protein. Past isolations of AMTV from gerbils, African grass rats, wild rats, typical striped grass mice, and shrews [18] 
